DNAPrint Genomics, Inc. (DNAG)
- Previous Close
0.0000 - Open
0.0000 - Bid --
- Ask --
- Day's Range
0.0000 - 0.0000 - 52 Week Range
0.0000 - 0.0001 - Volume
269,000 - Avg. Volume
124,025 - Market Cap (intraday)
644 - Beta (5Y Monthly) 28.10
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0090 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
DNAPrint Genomics, Inc. engages in the development and marketing of genetic testing products and services. It offers AncestryByDNA, a pan-chromosomal assay for genetic ancestry; EurasianDNA, which measures European sub-ancestry; EuropeanDNA, which reports a customer's proportional basic continental European ancestry; DNAWitness to determine genetic heritage from DNA samples obtained from crime scenes; RETINOME, which provides a physical portrait of a person of interest for a detective based on a DNA sample from a crime scene or remains of an individual; RETINOME, which allows infer eye color from DNA; and GenomeLab SNPstream Genotyping System, which offers genotyping rates and uses a multiplexing format to generate data with the minimum of reagents. The company serves forensic science, genealogical research, consumer products, and pharmaceutical development clients. DNAPrint Genomics, Inc. was formerly known as Lexington Energy, Inc. The company was incorporated in 1983 and is based in Sarasota, Florida with a subsidiary in Leverkusen, Germany.
24
Full Time Employees
December 31
Fiscal Year Ends
--
Sector
--
Industry
Related News
Performance Overview: DNAG
Trailing total returns as of 4/27/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: DNAG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: DNAG
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-235.65%
Return on Assets (ttm)
-105.00%
Return on Equity (ttm)
--
Revenue (ttm)
1.93M
Net Income Avi to Common (ttm)
-4.55M
Diluted EPS (ttm)
-0.0090
Balance Sheet and Cash Flow
Total Cash (mrq)
134.35k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-2.42M
Company Insights: DNAG
DNAG does not have Company Insights